Serum β2-microglobulin in systemic sclerosis
- 1 September 1985
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 4 (3) , 286-289
- https://doi.org/10.1007/bf02031609
Abstract
The role ofβ 2 microglobulin (β2-m) in Systemic Sclerosis (SS) has been evaluated. Twenty-four female patients have been examined: 15 of them were affected by acrosclerosis (Group 1) and 9 of them by diffuse sclerosis (Group 2). 46.6% of Group 1 and 44.4% of Group 2 had values significantly higher than normal controls. (P<0.01 and P< 0.005 respectively). The authors deal with the validity of the use of B2-m as index of inflammatory activity of the disease.Keywords
This publication has 21 references indexed in Scilit:
- Beta 2-microglobulin and its binding activity in serum from patients with SLE.Annals of the Rheumatic Diseases, 1984
- The Heart in Systemic SclerosisNew England Journal of Medicine, 1984
- Plasma Beta-2-Microglobulin and Fibronectin Levels in Beta-ThalassaemiaActa Haematologica, 1984
- Serum beta2microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.British Journal of Haematology, 1983
- Endothelial injury in scleroderma.The Journal of Experimental Medicine, 1979
- Plasma and urinary levels of beta2 microglobulin in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1978
- β2-MICROGLOBULIN, A TUMOUR MARKER OF LYMPHOPROLIFERATIVE DISORDERSThe Lancet, 1978
- Serum Beta-2-Microglobulin In Sjogren's SyndromeScandinavian Journal of Rheumatology, 1978
- Beta2Microglobulin and Lymphocytic Infiltration in Sjögren's SyndromeNew England Journal of Medicine, 1975
- Production of β2‐Microglobulin by Normal and Malignant Human Cell Lines and Peripheral LymphocytesImmunological Reviews, 1974